Post Profile






Mylan to Pay $465M Settlement Over Medicaid EpiPen Rebates

Mylan has become the latest poster child for pharmaceutical industry price-gouging
read more

share

Related Posts


Mylan to pay $465M settlement over EpiPen rebates

Business & Finance / Economics : Econwatch

Government says drug is branded, so drug company should have been paying a far higher reimbursement under pricing rules

Mylan to pay $465M settlement over EpiPen, cuts earnings outlook

Business & Finance : USAToday: Money

Mylan agreed to pay $465 million in a settlement over its pricing practices.        

Mylan to pay $465M settlement over EpiPen

Business & Finance : USAToday: Money

EpiPen maker Mylan agreed to pay $465 million in a settlement with federal regulators over its pricing practices        

Mylan to pay $465-million settlement over Medicaid EpiPen rebates

Business & Finance : LA Times: Business

Mylan will pay $465 million to settle allegations that it overbilled Medicaid for its life-saving EpiPen allergy injection. The federal government says EpiPen is a branded drug, which means Mylan should have been paying a far higher...

Mylan to pay $465 million over Medicaid pricing of EpiPen

Business & Finance : Mashable: Business

Mylan will pay the Department of Justice $465 million in a settlement over its pricing and classification of the EpiPen through Medicaid, the pharmaceutical company announced Friday.  Mylan, which came under fire this summer for sys...

Comments


Copyright © 2016 Regator, LLC